Sorry, we were unable to verify the authenticity of this link. If you would like to proceed anyway, click the link below.

https://www.gov.uk/drug-safety-update/daclizumab-zinbryta-and-risk-of-severe-liver-injury-initiation-in-multiple-sclerosis-now-restricted-promptly-review-patients-already-on-treatment